SK Bioscience Co Ltd chief executive Jaeyong Ahn said in a Financial Times interview that it is unlikely that the vaccine maker can supply COVID-19 vaccines to China amid its recent outbreak due to Beijing´s "national pride".

Ahn said that it was "unrealistic" to supply COVID vaccines to China, as the country insists on using its own, the newspaper quoted him as saying.

SK Bioscience is monitoring whether any COVID variants are emerging from China, the report said.